Similar articles for PMID: 26507838

Year	Number of Results
1996	2
1998	1
1999	1
2000	2
2001	1
2002	3
2003	3
2004	2
2005	1
2006	2
2007	4
2008	8
2009	5
2010	6
2011	5
2012	10
2013	7
2014	4
2015	13
2016	7
2017	21
2018	15
2019	11
2020	10
2021	7
2022	9
2023	1
2024	0

1

Biosynthesis of mercapturic acid derivative of the labdane-type diterpene, cyslabdan that potentiates imipenem activity against methicillin-resistant Staphylococcus aureus: cyslabdan is generated by mycothiol-mediated xenobiotic detoxification.

Ikeda H, Shin-Ya K, Nagamitsu T, Tomoda H. Ikeda H, et al. J Ind Microbiol Biotechnol. 2016 Mar;43(2-3):325-42. doi: 10.1007/s10295-015-1694-6. Epub 2015 Oct 27. J Ind Microbiol Biotechnol. 2016. PMID: 26507838

2

Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. I. Taxonomy, fermentation, isolation and structural elucidation.

Fukumoto A, Kim YP, Matsumoto A, Takahashi Y, Shiomi K, Tomoda H, Omura S. Fukumoto A, et al. J Antibiot (Tokyo). 2008 Jan;61(1):1-6. doi: 10.1038/ja.2008.101. J Antibiot (Tokyo). 2008. PMID: 18305352

3

Production of distinct labdane-type diterpenoids using a novel cryptic labdane-like cluster from Streptomyces thermocarboxydus K155.

Guzmán-Trampe SM, Ikeda H, Vinuesa P, Macías-Rubalcava ML, Esquivel B, Centeno-Leija S, Tapia-Cabrera SM, Mora-Herrera SI, Ruiz-Villafán B, Rodríguez-Sanoja R, Sanchez S. Guzmán-Trampe SM, et al. Appl Microbiol Biotechnol. 2020 Jan;104(2):741-750. doi: 10.1007/s00253-019-10240-3. Epub 2019 Dec 5. Appl Microbiol Biotechnol. 2020. PMID: 31807886

4

Chemical diversity of labdane-type bicyclic diterpene biosynthesis in Actinomycetales microorganisms.

Yamada Y, Komatsu M, Ikeda H. Yamada Y, et al. J Antibiot (Tokyo). 2016 Jul;69(7):515-23. doi: 10.1038/ja.2015.147. Epub 2016 Jan 27. J Antibiot (Tokyo). 2016. PMID: 26814669

5

Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities.

Fukumoto A, Kim YP, Hanaki H, Shiomi K, Tomoda H, Omura S. Fukumoto A, et al. J Antibiot (Tokyo). 2008 Jan;61(1):7-10. doi: 10.1038/ja.2008.102. J Antibiot (Tokyo). 2008. PMID: 18305353

6

The nonantibiotic small molecule cyslabdan enhances the potency of β-lactams against MRSA by inhibiting pentaglycine interpeptide bridge synthesis.

Koyama N, Tokura Y, Münch D, Sahl HG, Schneider T, Shibagaki Y, Ikeda H, Tomoda H. Koyama N, et al. PLoS One. 2012;7(11):e48981. doi: 10.1371/journal.pone.0048981. Epub 2012 Nov 6. PLoS One. 2012. PMID: 23166602 Free PMC article.

7

Synthesis and Structural Revision of Cyslabdan.

Ohtawa M, Hishinuma Y, Takagi E, Yamada T, Ito F, Arima S, Uchida R, Kim YP, Ōmura S, Tomoda H, Nagamitsu T. Ohtawa M, et al. Chem Pharm Bull (Tokyo). 2016;64(9):1370-7. doi: 10.1248/cpb.c16-00382. Chem Pharm Bull (Tokyo). 2016. PMID: 27581641 Free article.

8

[Mode of action of microbial anti-MRSA agents].

Tomoda H. Tomoda H. Yakugaku Zasshi. 2012;132(1):37-44. doi: 10.1248/yakushi.132.37. Yakugaku Zasshi. 2012. PMID: 22214578 Free article. Review. Japanese.

9

A novel mycothiol-dependent detoxification pathway in mycobacteria involving mycothiol S-conjugate amidase.

Newton GL, Av-Gay Y, Fahey RC. Newton GL, et al. Biochemistry. 2000 Sep 5;39(35):10739-46. doi: 10.1021/bi000356n. Biochemistry. 2000. PMID: 10978158

10

Biosynthesis and functions of mycothiol, the unique protective thiol of Actinobacteria.

Newton GL, Buchmeier N, Fahey RC. Newton GL, et al. Microbiol Mol Biol Rev. 2008 Sep;72(3):471-94. doi: 10.1128/MMBR.00008-08. Microbiol Mol Biol Rev. 2008. PMID: 18772286 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

145 results

Results by year